Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Show more
Location: RUE EDOUARD BELIN 12, MONT-SAINT-GUIBERT, BELGIUM, 1435, Mont-Saint-Guibert, 1435, USA | Website: https://www.nyxoah.com | Industry: MEDICAL INSTRUMENTS & SUPPLIES | Sector: HEALTHCARE
Market Cap
206M
52 Wk Range
$4.34 - $11.87
Previous Close
$4.59
Open
$4.68
Volume
9,954
Day Range
$4.60 - $4.72
Enterprise Value
194.7M
Cash
10.87M
Avg Qtr Burn
-20.49M
Insider Ownership
37.58%
Institutional Own.
22.23%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
